The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008.
暂无分享,去创建一个
R. Labianca | D. Kerr | J. Berlin | W. Scheithauer | K. Haustermans | E. Van Cutsem | B. Nordlinger | T. Gruenberger | M. Ducreux | J. Tabernero | D. Haller | M. Moore | C. Verslype | P. Rougier | N. Arber | D. Cunningham | A. Ohtsu | P. Hoff | A. de Gramont | A. Gramont | H. Schmoll | E. Díaz-Rubio | A. Sobrero | M. Moore | C. J. van de Velde | M. Dicato | C. Velde | H. Schmoll | Karin Haustermans | E. Cutsem | Josep Tabernero | Nadir Arber | David J. Kerr | C.J.H. van de Velde | H. J. Schmoll | Mario Dicato | Malcolm J. Moore | D. Cunningham | A. de Gramont | E. Van Cutsem | Bernard Nordlinger | Chris Verslype | Jordan Berlin | David Cunningham | Eduardo Díaz-Rubio | Michel Ducreux | Daniel G. Haller | Paulo M. Hoff | Roberto Labianca | Werner Scheithauer | Alberto Sobrero | Nadir Arber
[1] Tae Hyun Kim,et al. A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea , 2009, Liver international : official journal of the International Association for the Study of the Liver.
[2] Dieter Häussinger,et al. Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.
[3] X. Paoletti,et al. Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] M. Makuuchi,et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. , 2008, Gastroenterology.
[5] Eva Pagano,et al. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial , 2008, Scandinavian journal of gastroenterology.
[6] T. Roskams,et al. Nuclear β‐catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy , 2007, Histopathology.
[7] Laura Crocetti,et al. Clinical management of focal liver lesions: the key role of real-time contrast-enhanced US , 2007, European radiology.
[8] A. Benson,et al. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis , 2007, Hepatology.
[9] Cristel G. Thomas,et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry , 2007, Hepatology.
[10] A. Burroughs,et al. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. , 2007, Cancer treatment reviews.
[11] G. Giannelli,et al. New frontiers in biomarkers for hepatocellular carcinoma. , 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[12] Mi-Suk Park,et al. Newly Developed Hepatocellular Carcinoma (HCC) in Chronic Liver Disease: MR Imaging Findings Before the Diagnosis of HCC , 2006, Journal of computer assisted tomography.
[13] E. Lesaffre,et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin , 2006, Histopathology.
[14] Farin Kamangar,et al. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] J. Bruix,et al. Management of hepatocellular carcinoma , 2005, Hepatology.
[16] Guy Marchal,et al. Local Recurrence After Hepatic Radiofrequency Coagulation: Multivariate Meta-Analysis and Review of Contributing Factors , 2005, Annals of surgery.
[17] M. Stockler,et al. Use of tamoxifen in advanced‐stage hepatocellular carcinoma , 2005, Cancer.
[18] L. Mariani,et al. Radiofrequency Ablation of Small Hepatocellular Carcinoma in Cirrhotic Patients Awaiting Liver Transplantation: A Prospective Study , 2004, Annals of surgery.
[19] S. Thorgeirsson,et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling , 2004, Hepatology.
[20] L. Bolondi,et al. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. , 2004, Journal of hepatology.
[21]
Katsuyoshi Ito,et al.
Cirrhosis or chronic hepatitis: evaluation of small (
[22] S. Hussain,et al. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. , 2002, Radiographics : a review publication of the Radiological Society of North America, Inc.
[23] T. Roskams,et al. Focal lesions in cirrhotic explant livers: Pathological evaluation and accuracy of pretransplantation imaging examinations , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[24] Ramon Planas,et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.
[25] John Wong,et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.
[26] L Pagliaro,et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.
[27] F. Izzo,et al. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients , 1998, Hepatology.
[28] M. Lai,et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. , 1997, The New England journal of medicine.
[29] V. Mazzaferro,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[30] H. Popper. American Association for the Study of Liver Diseases: Symposium on Toxic Hepatic Injury , 1960 .
[31] L. Mariani,et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. , 2009, The Lancet. Oncology.
[32] S. Schoenberg,et al. Dual breath-hold magnetic resonance cine evaluation of global and regional cardiac function , 2006, European Radiology.
[33] Carlo Bartolozzi,et al. Imaging diagnosis. , 2005, Seminars in liver disease.
[34] T. Roskams,et al. Early hepatocellular carcinoma and dysplastic nodules. , 2005, Seminars in liver disease.
[35] C. Bartolozzi,et al. Magnetic resonance imaging of liver tumors. , 2004, Journal of hepatology.
[36] J. Bruix,et al. Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.